Evotec SE (EVOTF)
OTC
Real-time Data
01:30 PM
Day's Range
6.6952 wk Range
4.72Overview - EVOTF - Evotec SE
Key Statistics
Valuation
Enterprise Value
820.95M
P/E (Trailing)
‪-11.53‬
PEG Ratio
‪-0.04‬
Price / Sales (TTM)
‪1.65‬
Price / Book
‪1.52‬
EV / EBITDA
‪-9.58‬
Profitability
Gross Margin
‪-1.00%‬
Profit Margin
‪-27.47%‬
Operating Margin
‪-62.25%‬
Return on Assets
‪-5.39%‬
Return on Equity
‪-26.07%‬
Ownership
Shares Outstanding
177.59M
Float
135.38M
Held by Insiders
‪9.96%‬
Held by Institutions
‪61.24%‬
Price stats
Beta
‪1.26‬
50-Day Avg
‪6.69‬
200-Day Avg
‪6.97‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - EVOTF - Evotec SE
Peers - EVOTF - Evotec SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- EVOTFOTCEvotec SE1.18BMarket Cap-27.29%52-week change-11.53P/E (Trailing)‪-27.47%‬Profit Margin
- MKGAFOTCMerck KGaA70.96BMarket Cap+22.06%52-week change23.97P/E (Trailing)‪11.21%‬Profit Margin
- MKKGYOTCMerck KGaA Sponsored ADR70.08BMarket Cap+20.60%52-week change23.88P/E (Trailing)‪11.21%‬Profit Margin
- JHPCYOTCJiangsu Hengrui Pharmaceuticals Co. Ltd.66.37BMarket Cap+15.20%52-week change58.82P/E (Trailing)‪86.20%‬Profit Margin
- GALDYOTCGalderma Group AG Unsponsored ADR49.85BMarket Cap+20.44%52-week change58.64P/E (Trailing)‪14.57%‬Profit Margin
- GDERFOTCGalderma Group AG47.80BMarket Cap+25.78%52-week change66.16P/E (Trailing)‪14.57%‬Profit Margin
- HLNCFOTCHaleon plc42.44BMarket Cap-1.14%52-week change19.24P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - EVOTF - Evotec SE
About
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrated drug discovery solutions on a fee-for-service basis or via…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
